UBE2D3
Ubiquitin-conjugating enzyme E2 D3
Also known as: UB2D3_HUMAN, UbcH5C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61077
- Gene
- UBE2D3
- Ensembl
- ENSG00000109332
- Chromosome
- 4
- Canonical length
- 147 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme functions in the ubiquitination of the tumor-suppressor protein p53, which is induced by an E3 ubiquitin-protein ligase. [provided by RefSeq, Jan 2017]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>P61077|UBE2D3
1 MALKRINKEL SDLARDPPAQ CSAGPVGDDM FHWQATIMGP NDSPYQGGVF FLTIHFPTDY
61 PFKPPKVAFT TRIYHPNINS NGSICLDILR SQWSPALTIS KVLLSICSLL CDPNPDDPLV
121 PEIARIYKTD RDKYNRISRE WTQKYAMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2D3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 452 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 452 nTPM
- liver: 235 nTPM
- skeletal muscle: 230 nTPM
- tongue: 185 nTPM
- thymus: 185 nTPM
- tonsil: 184 nTPM
Single-cell type
- neutrophils: 1,721 nCPM
- esophageal apical cells: 1,698 nCPM
- oocytes: 1,156 nCPM
- late spermatids: 891 nCPM
- early spermatids: 880 nCPM
- syncytiotrophoblasts: 837 nCPM
Immune cell
- neutrophil: 823 nTPM
- basophil: 617 nTPM
- total PBMC: 423 nTPM
- eosinophil: 395 nTPM
- non-classical monocyte: 273 nTPM
- intermediate monocyte: 256 nTPM
Brain region
- cerebral cortex: 200 nTPM
- white matter: 199 nTPM
- hypothalamus: 189 nTPM
- medulla oblongata: 187 nTPM
- spinal cord: 181 nTPM
- pons: 179 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about UBE2D3.
Disease | ImmuneIEDB
Conditions an epitope on UBE2D3 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0.41
- gnomAD missense Z
- 2.99
- DepMap mean gene effect
- -0.72
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- DNA repair
- negative regulation of BMP signaling pathway
- negative regulation of transcription by RNA polymerase II
- positive regulation of protein targeting to mitochondrion
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein autoubiquitination
- protein K11-linked ubiquitination
- protein K48-linked ubiquitination
- protein K6-linked ubiquitination
- protein modification process
- protein monoubiquitination
- protein polyubiquitination
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ATP binding
- ubiquitin conjugating enzyme activity
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2D3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2D3 as an antibody target. Whether an autoantibody or antibody against UBE2D3 could matter depends on whether native UBE2D3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2D3 is annotated at the cell surface, where native UBE2D3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label UBE2D3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...